Filing Details

Accession Number:
0000899243-20-035535
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-30 18:19:12
Reporting Period:
2020-12-28
Accepted Time:
2020-12-30 18:19:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1717452 Odonate Therapeutics Inc. ODT () 1231
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1015747 Joseph Lewis C/o Cay House, Ep Taylor Drive
Lyford Cay
New Providence C5 N7776
No No Yes No
1465836 Boxer Asset Management Inc. C/o Cay House, Ep Taylor Drive N7776
Lyford Cay
New Providence C5
No No Yes No
1465837 Boxer Capital, Llc 12860 El Camino Real, Suite 300
San Diego CA 92130
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-12-28 75,000 $16.90 5,282,086 No 4 P Direct
Common Stock Acquisiton 2020-12-28 225,000 $17.11 5,507,086 No 4 P Direct
Common Stock Acquisiton 2020-12-30 100,000 $17.46 5,607,086 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. These securities are owned directly by Boxer Capital, LLC ("Boxer Capital"), which may be deemed to be a member of a "group" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, (ii) Boxer Asset Management Inc. ("Boxer Management"), (iii) Aaron I. Davis, and (iv) Joseph C. Lewis (collectively, the "Boxer Group"). Each member of the Boxer Group other than Boxer Capital disclaims beneficial ownership of these securities to the extent it or he does not have a pecuniary interest therein.
  2. These securities are owned indirectly by Boxer Management and Joseph C. Lewis, by virtue of their ownership of Boxer Capital.
  3. Reflects the weighted average purchase price. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. The range of prices for such transaction is $16.75 to $17.29.
  4. Reflects the weighted average purchase price. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by abroker dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The reporting person hereby undertakes to provide upon request by theSecurities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price. The range of prices for such transactionis $16.89 to $17.72.